Societe D'etudes Scientifiques Et Industrielles De L'ile-de-france

Societe D'etudes Scientifiques Et Industrielles

Jacques J Perrot

Michel Leon Thominet

N-(1-allyl-2-pyrrolidinyl-methyl) 2-methoxy-4-amino-5-methylsulfamoyl benide and derivatives thereof, which are useful in the treatment of anomalies in cerebral hemodynamics of patients subject to migraines.

N-(1-Allyl-2-pyrrolidinyl-methyl) 2-methoxy-4-amino-5-methylsulfamoyl

N-(1'-allyl-2'-pyrrolidylmethyl)-2,3-dimethoxy-5-sulfamoylbenzamide and dvatives thereof and method for treating the psycho neuro-vegetative syndrome of the natural or surgical menopause by administering an effective amount of said compound to a patient.

N-(1-allyl-2-pyrrolidylmethyl)-2,3-dimethoxy-5-sulfamoylbenzamide and

N-(1-allyl-2-pyrrolidinyl-methyl)2-methoxy-4-amino-5-methylsulfamoyl benzde and derivatives thereof, which are useful in the treatment of anomalies in cerebral hemodynamics of patients subject to migraines.

N-(1-Allyl-2-pyrrolidinyl-methyl)2-methoxy-4-amino-5-methylsufamoyl

The present invention relates to a novel veratramide, N-(1-methyl-2-pyrroinyl-methyl)-2,3-dimethoxy-5-methylsulphamoyl benzamide, its pharmacologically acceptable acid addition salts, its quaternary ammonium salts, its oxides and its levorotatory and dextrorotatory isomers and their use in the treatment of disorders of the lower urinary apparatus.

N-(1-Methyl-2-pyrrolidinylmethyl)-2,3-dimethoxy-5-methylsulfamoyl

The present invention concerns a novel medicament based on aspirin and heptaminol (that is to say, 6-amino-2-methyl-2-heptanol).

Growing community of inventors

Paris, France

Jacques J Perrot